Kari C Nadeau Selected Research

Food Hypersensitivity (Food Allergy)

2/2022	Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study.
12/2021	Food allergy across the globe.
1/2021	The importance of the 2S albumins for allergenicity and cross-reactivity of peanuts, tree nuts, and sesame seeds.
1/2021	Targeted DNA methylation profiling reveals epigenetic signatures in peanut allergy.
1/2021	A positive feedback loop reinforces the allergic immune response in human peanut allergy.
11/2020	The origins of allergy from a systems approach.
3/2020	Microfluidic methods for precision diagnostics in food allergy.
1/2020	Food Allergy from Infancy Through Adulthood.
1/2020	Oral Immunotherapy and Basophil and Mast Cell Reactivity in Food Allergy.
1/2020	Can food allergy be cured? What are the future prospects?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kari C Nadeau Research Topics

Disease

40	Food Hypersensitivity (Food Allergy) 02/2022 - 02/2012
35	Hypersensitivity (Allergy) 10/2022 - 10/2008
25	COVID-19 03/2022 - 08/2020
24	Asthma (Bronchial Asthma) 01/2022 - 12/2007
13	Inflammation (Inflammations) 01/2022 - 10/2008
12	Peanut Hypersensitivity (Peanut Allergy) 10/2022 - 01/2011
11	Infections 03/2022 - 08/2014
6	Anaphylaxis (Anaphylactic Shock) 01/2021 - 06/2016
4	Atopic Dermatitis (Atopic Eczema) 01/2022 - 07/2017
4	Eosinophilic Esophagitis 01/2017 - 09/2010
3	Eczema 02/2022 - 07/2017
3	Human Influenza (Influenza) 01/2022 - 01/2021
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2016
2	Enterocolitis 02/2022 - 01/2020
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 01/2021
2	Celiac Disease (Celiac Sprue) 01/2022 - 12/2021
2	Disease Progression 01/2022 - 12/2021
2	Lung Diseases (Lung Disease) 01/2022 - 11/2021
2	Allergic Rhinitis 05/2017 - 01/2015
2	Neoplasms (Cancer) 03/2016 - 12/2009
2	Nut Hypersensitivity (Nut Allergy) 06/2012 - 01/2011
1	Tetanus 06/2022
1	Coinfection 03/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Rheumatoid Arthritis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Vesicular Stomatitis 01/2022
1	Vascular System Injuries 11/2021

Drug/Important Bio-Agent (IBA)

29	AllergensIBA 10/2022 - 01/2011
22	Immunoglobulin E (IgE)IBA 12/2021 - 07/2012
15	Immunoglobulin G (IgG)IBA 06/2022 - 09/2017
15	AntibodiesIBA 01/2022 - 02/2014
11	CytokinesIBA 01/2022 - 12/2007
10	Proteins (Proteins, Gene)FDA Link 02/2022 - 12/2016
9	Messenger RNA (mRNA)IBA 03/2022 - 01/2021
9	VaccinesIBA 01/2022 - 10/2020
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2007
7	AntigensIBA 01/2022 - 02/2014
6	COVID-19 VaccinesIBA 01/2022 - 01/2021
6	mRNA VaccinesIBA 01/2022 - 01/2021
6	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020 - 07/2013
6	Omalizumab (Xolair)FDA Link 01/2020 - 01/2011
4	RNA (Ribonucleic Acid)IBA 03/2022 - 12/2018
4	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2021
4	anti-IgE antibodiesIBA 01/2020 - 02/2012
3	EmollientsIBA 10/2022 - 01/2020
3	AutoantibodiesIBA 01/2022 - 11/2015
3	LigandsIBA 01/2022 - 01/2021
3	BNT162 VaccineIBA 01/2022 - 04/2021
3	Monoclonal AntibodiesIBA 01/2022 - 02/2012
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2022 - 10/2020
2	AutoantigensIBA 01/2022 - 01/2021
2	KIR ReceptorsIBA 01/2022 - 12/2021
2	IgG Receptors (Fc gamma RI)IBA 01/2022 - 01/2020
2	GliadinIBA 01/2022 - 12/2021
2	Biological ProductsIBA 01/2022 - 02/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 12/2020
2	Peptides (Polypeptides)IBA 11/2021 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 11/2021 - 08/2020
2	Antiviral Agents (Antivirals)IBA 10/2021 - 04/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2021 - 12/2020
2	Immunoglobulin A (IgA)IBA 04/2021 - 10/2020
2	Polysaccharides (Glycans)IBA 01/2021 - 11/2020
2	ChromatinIBA 01/2021 - 11/2016
2	EpitopesIBA 01/2021 - 01/2016
2	Immunoglobulins (Immunoglobulin)IBA 10/2019 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 03/2010
2	Tobacco Smoke Pollution (Passive Smoking)IBA 03/2016 - 01/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2015 - 12/2007
2	ChemokinesIBA 04/2009 - 10/2008
1	SteroidsIBA 10/2022
1	Cytidine Diphosphate Diglycerides (CDP-Diacylglycerol)IBA 06/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022
1	remdesivirIBA 01/2022
1	BIBP COVID-19 vaccineIBA 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Ad26COVS1IBA 01/2022
1	Viral AntigensIBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	SphingosineIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2021
1	Excipients (Suspending Agents)IBA 12/2021
1	ProteomeIBA 11/2021
1	AngiotensinsIBA 11/2021
1	InflammasomesIBA 10/2021
1	SARS-CoV-2 spike proteinIBA 04/2021
1	Immunoglobulin M (IgM)IBA 04/2021
1	Viral RNAIBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	LeguminsIBA 01/2021

Therapy/Procedure

26	Immunotherapy 01/2022 - 02/2012
17	Therapeutics 01/2022 - 06/2011
3	Aftercare (After-Treatment) 01/2021 - 12/2009
3	Dietary Approaches To Stop Hypertension 01/2021 - 07/2013
1	Reducing Diet 11/2021